Unsurprisingly, the Fed finally got the message from the markets and pulled a hard 180 last month. In a very short six weeks, they went from “balance sheet runoff on autopilot and more rate increases to come in 2019” to “we’re pausing rate increases and we’ll be flexible with the balance sheet.” Risk assets have…
Here’s my brain dump on the recent market action and how I’m approaching things: Since stocks started to slide in October, I’ve been seeing signals that only appear during bear markets so I’ve been operating under that assumption by reducing exposure to higher risk assets (stocks, corporate bonds, etc.) on bounces. We’re now…
Macro changes occur at a glacial speed but these are typically the most important metrics to track. This is separating the signal (macro shifts, leading data points, etc.) from the noise (CNBC). Warning Signals from the Yield Curve One of the most basic yet crucial metrics is the yield curve, which has certainly received a…
The 10-year Treasury yield stopped just short of 3% last week and the recent Commitment of Trader’s data is showing massive short exposure to the 10-year futures contract by non-commercial traders. These are speculative positions betting that the 10-year yield will continue to rise (bond prices will continue to fall). The market has a funny…
Pfizer and Allergan have announced a “merger” where Pfizer is essentially acquiring Allergan so it can perform a tax inversion to relocate to Ireland (where Allergan is based). This is the second time Allergan has been acquired since we purchased it back in June, 2013, with the first being the takeover by Actavis last fall. Then…
China The Chinese stock market has probably been the hottest market over the last year. While exciting for the time being, I don’t trust it one bit. The Chinese economy has been supported by an unsustainable increase in credit the past few years and the bubble has the potential to pop at any moment. There…